COPD

May 13, 2016May 13, 2016

GlaxoSmithKline (GSK) to Present Studies on Respiratory Diseases Therapies at ATS 2016

Asthma, COPD, News

GlaxoSmithKline (GSK) recently announced that the company will present the most recent results obtained in a wide range of GSK studies, focused on their respiratory portfolio of approved medicines, at ... Read more

May 13, 2016May 13, 2016

ATS 2016 International Conference Features Keynote Series

COPD, Idiopathic Pulmonary Fibrosis, News, Pulmonary Hypertension

The American Thoracic Society (ATS) is hosting the ATS 2016 International Conference through May 18 in San Franscico, Calif. This year’s conference will feature the ATS Keynote Series with eight ... Read more

May 11, 2016May 11, 2016

Sunovion to Present New Data on Brovana Inhalation Solution for COPD

Chronic Bronchitis, COPD, Emphysema, News

Sunovion Pharmaceuticals, Inc. will present new data analyses regarding its Brovana® (arformoterol tartrate) Inhalation Solution, from clinical and health outcomes in chronic obstructive pulmonary disease (COPD) patients, at the 2016 American ... Read more

May 9, 2016May 9, 2016

Asthma and Lung Damage Study Led by Hospital for Sick Children Receives Funding from Canadian Institutes of Health Research

Asthma, COPD, News

A study led by Hospital for Sick Children (SickKids) researchers investigating the influence of genes and environment on lung health will receive $1.9 million in funding over the next five years. ... Read more

May 3, 2016May 4, 2016

FDA Approves COPD Treatment Bevespi Aerosphere, a Long-acting Dual Bronchodilator

Chronic Bronchitis, COPD, Emphysema, News

The U.S. FDA has approval AstraZeneca’s Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) for long-term maintenance treatment of airflow obstruction in patients suffering from chronic obstructive pulmonary disease (COPD), including emphysema and/or chronic bronchitis. ... Read more

May 2, 2016October 17, 2016

Phase 3 Clinical Trials for COPD Treatment Return Positive Results, Sunovion Reports

COPD, News

Sunovion Pharmaceuticals, a biopharma focused on the development of medical solutions for respiratory, neurological, and psychiatric conditions, recently announced positive results from the Phase 3 trial program assessing SUN-101 (glycopyrrolate) for ... Read more

April 28, 2016May 31, 2016

Scientists Discover Shared Genes in COPD and IPF, Pointing to Potential Drug Development

COPD, Emphysema, Idiopathic Pulmonary Fibrosis, News

Despite sharing some risk factors, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are usually studied in isolation, and the presence of possible shared molecular mechanisms has been unknown. Now, in a new study ... Read more

April 27, 2016April 27, 2016

Physical Therapy Program Improves COPD Patients’ Quality of Life, Researchers Say

COPD, News

Researchers at the University of Granada (UGR) and Virgen de las Nieves Hospital, Spain, developed a brief physical therapy treatment of 7 to 10 days that demonstrates it can improve ... Read more

April 26, 2016April 26, 2016

Aptar Introduces an eDose Counter Aiming to Make Asthma and COPD Inhalers Easier to Use

Asthma, COPD, News

Aptar Pharma, which specializes in injection, aerosol, and spray delivery systems for healthcare and biotech products, unveiled its newest improvement to metered dose inhaler (MDIs) at the recent RDD scientific conference in ... Read more

April 22, 2016April 23, 2016

3M Designs an ‘Intelligent Inhaler’ System for COPD, Asthma and Other Respiratory Ills

Asthma, COPD, News

According to the World Health Organization, about 334 million individuals globally are afflicted with asthma, and 65 million suffer from moderate to severe chronic obstructive pulmonary disease (COPD) — a number expected to ... Read more